ClinicalTrials.Veeva

Menu

Role of ChatGPT in Vestibular Schwannoma Management

University of Southern California logo

University of Southern California

Status

Withdrawn

Conditions

Vestibular Schwannoma

Treatments

Behavioral: Use of chatGPT for 1 week

Study type

Interventional

Funder types

Other

Identifiers

NCT06163664
UP-23-00541

Details and patient eligibility

About

Previous studies have demonstrated that patients frequently undergo significant decision conflict regarding major medical decisions in otolaryngology. There lack validated tools available for decision support for patients. While limited evidence has demonstrated that clinical decision support tools can alleviate decision conflict for patients with diagnosis in otolaryngology, conversational language models were not employed in these studies and may provide additional benefit in this context. This study seeks to evaluate the efficacy of using ChatGPT, a conversational language model with basic clinical knowledge, in alleviating decision conflict for patients with new diagnosis in otolaryngology. For this pilot study, vestibular schwannoma, a benign tumor that develops on the vestibular nerve with known clinical equipoise, has been chosen for the initial study diagnosis. Efficacy will be evaluated by comparison of responses to the Decisional Conflict Scale (DCS) and Satisfaction with Decision (SWD) scores between a group given training in ChatGPT and a control group (no ChatGPT training).

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18 years or older
  • Diagnosed with vestibular schwannoma
  • Have access to internet-enabled device that is compatible with ChatGPT

Exclusion criteria

  • < 18 years old
  • patient without diagnosis of vestibular schwannoma
  • patient does not have access to internet-enabled device
  • patient who declines study participation

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

Intervention
Experimental group
Description:
Intervention with 1 week use of ChatGPT
Treatment:
Behavioral: Use of chatGPT for 1 week
Delayed control
Active Comparator group
Description:
No ChatGPT use for 1 week and intervention after 1 week
Treatment:
Behavioral: Use of chatGPT for 1 week

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems